Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Episodic ataxia type 7 (EA7) is an exceedingly rare form of Hereditary episodic ataxia characterized by ataxia with weakness, vertigo, and dysarthria without interictal findings.
Features include very common findings: Vertigo, Episodic ataxia, Dysarthria, and Muscle weakness; and common findings: Nystagmus. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Episodic ataxia, Dysarthria, Migraine |
Biomarker and diagnostic research for episodic ataxia type 7 has been reported in the published literature.
Phenotype severity distribution: 4 very common features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
11 publications have been identified in PubMed for episodic ataxia type 7. Research spans Case Report / Case Series (45%), Diagnostic / Biomarker (27%), and Other (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 45% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:12 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Vertigo, Tinnitus |
Eyes | 2 | Nystagmus, Diplopia |
Muscles | 1 | Muscle weakness |
Testing and diagnosis research |
3 |
27% |
Other research | 1 | 9% |
Research summaries | 1 | 9% |
Laboratory research | 1 | 9% |
Pons NC (2026). [PMID: 42090775](https://pubmed.ncbi.nlm.nih.gov/42090775/). *J Neurol Sci*. [Diagnostic / Biomarker]
Wang Q (2026). [PMID: 41391423](https://pubmed.ncbi.nlm.nih.gov/41391423/). *Seizure*. [Case Report / Case Series]
Park S (2026). [PMID: 42073066](https://pubmed.ncbi.nlm.nih.gov/42073066/). *Children (Basel)*. [Case Report / Case Series]
Chinigioli M (2026). [PMID: 41370964](https://pubmed.ncbi.nlm.nih.gov/41370964/). *Eur J Paediatr Neurol*. [Diagnostic / Biomarker]
Cundari M (2025). [PMID: 41445982](https://pubmed.ncbi.nlm.nih.gov/41445982/). *Frontiers in computational neuroscience*. [Case Report / Case Series]
Pretegiani E (2025). [PMID: 40801974](https://pubmed.ncbi.nlm.nih.gov/40801974/). *Cerebellum (London, England)*. [Review / Meta-Analysis]
Romozzi M (2025). [PMID: 39723107](https://pubmed.ncbi.nlm.nih.gov/39723107/). *Brain communications*. [Other]
Li X (2025). [PMID: 35817592](https://pubmed.ncbi.nlm.nih.gov/35817592/). *Ear, nose, & throat journal*. [Diagnostic / Biomarker]
von der Gablentz J (2025). [PMID: 41169271](https://pubmed.ncbi.nlm.nih.gov/41169271/). *Brain communications*. [Case Report / Case Series]
Kim S (2024). [PMID: 39505308](https://pubmed.ncbi.nlm.nih.gov/39505308/). *Journal of clinical neurology (Seoul, Korea)*. [Basic Science / Preclinical]